Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pharming Group N.V. ADR (PHAR)

Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pharming Group N.V. ADR DARWINWEG 24 LEIDEN P7 2333 CR NLD

www.pharming.com P: 31-71-524-7400 F: +31 715247445

Description:

Pharming Group N.V. is a commercial stage biopharmaceutical company. It engages in developing protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs. The company's product portfolio includes C1INH. Pharming Group N.V. is based in Leiden, The Netherlands.

Key Statistics

Overview:

Market Capitalization, $K 542,119
Enterprise Value, $K 482,199
Shares Outstanding, K 67,344
Annual Sales, $ 245,320 K
Annual Net Income, $ -10,550 K
Last Quarter Sales, $ 55,590 K
Last Quarter Net Income, $ -12,450 K
EBIT, $ -14,410 K
EBITDA, $ 1,520 K
60-Month Beta 0.15
% of Insider Shareholders 2.07%
% of Institutional Shareholders 0.03%
Float, K 65,950
% Float 97.93%
Short Volume Ratio 0.01

Growth:

1-Year Return -30.90%
3-Year Return -30.62%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.19 on 05/08/24
Next Earnings Date 08/01/24
Earnings Per Share ttm -0.15
EPS Growth vs. Prev Qtr -533.33%
EPS Growth vs. Prev Year -11.76%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PHAR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -4.61%
Return-on-Assets % -2.18%
Profit Margin % -4.30%
Debt/Equity 0.65
Price/Sales 2.29
Price/Cash Flow 85.67
Price/Book 2.72
Book Value/Share 3.07
Interest Coverage -0.92
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar